Display options
Share it on

Radiol Bras. 2014 May-Jun;47(3):159-64. doi: 10.1590/0100-3984.2013.1859.

Current situation of high-dose-rate brachytherapy for cervical cancer in Brazil.

Radiologia brasileira

Rogério Matias Vidal da Silva, Juliana Castro Dourado Pinezi, Luiz Eduardo Andrade Macedo, Divanízia do Nascimento Souza

Affiliations

  1. Master, Fellow PhD degree in Physics, Universidade Federal de Sergipe (UFS), São Cristóvão, SE, Brazil.
  2. Master, Professor, Pontifícia Universidade Católica de Goiás (PUC Goiás), Goiânia, GO, Brazil.
  3. Specialist in Medical Physics, Physicist at Hospital Chama, Arapiraca, AL, Brazil.
  4. PhD, Professor, Universidade Federal de Sergipe (UFS), São Cristóvão, SE, Brazil.

PMID: 25741073 PMCID: PMC4337132 DOI: 10.1590/0100-3984.2013.1859

Abstract

OBJECTIVE: To assess the current situation of high-dose-rate (HDR) brachytherapy for cancer of the cervix in Brazil, regarding apparatuses, planning methods, prescription, fractionation schedule and evaluation of dose in organs at risk.

MATERIALS AND METHODS: In the period between March/2012 and May/2013, a multiple choice questionnaire was developed and sent to 89 Brazilian hospitals which perform HDR brachytherapy.

RESULTS: Sixty-one services answered the questionnaire. All regions of the country experienced a sharp increase in the number of HDR brachytherapy services in the period from 2001 to 2013. As regards planning, although a three-dimensional planning software was available in 91% of the centers, conventional radiography was mentioned by 92% of the respondents as their routine imaging method for such a purpose. Approximately 35% of respondents said that brachytherapy sessions are performed after teletherapy. The scheme of four 7 Gy intracavitary insertions was mentioned as the most frequently practiced.

CONCLUSION: The authors observed that professionals have difficulty accessing adjuvant three-dimensional planning tools such as computed tomography and magnetic resonance imaging.

Keywords: Brachytherapy; Brazil; Cancer; Cervix; Research; Uterus

References

  1. Br J Radiol. 2003 Dec;76(912):897-903 - PubMed
  2. Brachytherapy. 2012 Jan-Feb;11(1):33-46 - PubMed
  3. Radiother Oncol. 2001 Jan;58(1):53-62 - PubMed
  4. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1108-16 - PubMed
  5. Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):359-66 - PubMed
  6. Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1275-88 - PubMed
  7. Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S43-103 - PubMed
  8. Radiother Oncol. 2006 Jan;78(1):67-77 - PubMed
  9. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):250-5 - PubMed
  10. Radiother Oncol. 2013 Apr;107(1):13-9 - PubMed
  11. Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1301-7 - PubMed
  12. Brachytherapy. 2009 Apr-Jun;8(2):240-7 - PubMed
  13. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1157-64 - PubMed
  14. Radiother Oncol. 2005 Mar;74(3):235-45 - PubMed
  15. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):131-7 - PubMed
  16. Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):791-6 - PubMed
  17. Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1051-6 - PubMed
  18. Brachytherapy. 2008 Jul-Sep;7(3):260-6 - PubMed

Publication Types